• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

RITODRINE Drug Record

  • Summary
  • Interactions
  • Claims
  • RITODRINE chembl:CHEMBL83063 Approved

    Alternate Names:

    DU-21220
    RITODRINE

    Drug Info:

    FDA Approval Approved before 1982
    Drug Class small molecule
    Drug Indications Tocolytic Agents
    Year of Approval approved before 1982
    Drug Class tocolytic agents
    (1 More Sources)

    Publications:

    Baek MY et al., 2017, Association between CACNA1C gene polymorphisms and ritodrine-induced adverse events in preterm labor patients., Eur J Clin Pharmacol
    Bianchetti et al., 1990, In vitro inhibition of intestinal motility by phenylethanolaminotetralines: evidence of atypical beta-adrenoceptors in rat colon., Br. J. Pharmacol.
    Schwarz et al., 2003, Preterm labour: an overview of current and emerging therapeutics., Curr. Med. Chem.
    Lye et al., 1992, Failure of ritodrine to prevent preterm labor in the sheep., Am. J. Obstet. Gynecol.
    Tanaka et al., 2001, Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence., J. Med. Chem.
    Lenselink et al., 1994, Cardiovascular teratogenicity of terbutaline and ritodrine in the chick embryo., Am. J. Obstet. Gynecol.
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
  • RITODRINE   ADRB2

    Interaction Score: 2.42

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    PMIDs:
    1976401 12871140 1332478 11311067 8059831 11752352


    Sources:
    TdgClinicalTrial TEND PharmGKB TTD

  • RITODRINE   CACNA1C

    Interaction Score: 1.99

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    28391406


    Sources:
    PharmGKB

  • TEND: RITODRINE

    • Version: 01-August-2011

    Alternate Names:
    RITODRINE Primary Drug Name

    Drug Info:
    Drug Class tocolytic agents
    Year of Approval approved before 1982

    Publications:

  • TdgClinicalTrial: RITODRINE

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Tocolytic Agents
    Drug Class small molecule
    FDA Approval Approved before 1982

    Publications:

  • PharmGKB: ritodrine

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Baek MY et al., 2017, Association between CACNA1C gene polymorphisms and ritodrine-induced adverse events in preterm labor patients., Eur J Clin Pharmacol

  • TTD: Ritodrine

    • Version: 2020.06.01

    Alternate Names:
    D00LFB TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL83063

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21